Dr. Ying Mu is currently working as Toxicologist and Principal Investigator at the FDA, Center for Devices and Radiological Health (CDRH). He has completed his Ph.D. in Orthopaedics from Gunma University, Japan. He is having over 20 years research experience with broad array of knowledge in Orthopedics, Toxicology, Immunology, Medicine, Clinically Relevant Biomarkers Discovery and Applications, Biomaterials, Biocompatibility and Analytical Chemistry, pre-Market Risk Assessments and Post-Market Safety evaluation including hands-on Orthopedics experience, Toxicological Research, and Pharmacology/Toxicology reviewer at Center for Drug Evaluation and Research (CDER). Previously he was appointed as Principal Investigator and Research Assistant Professor at University of Pittsburgh, PA, USA. He is member of the Society of Toxicology, The FDA Biocompatibility Standards Technical Group, The FDA Nitinol Interest Group, and The FDA Nanotech Reviewer Network. He has published 25 research articles in journals as author/co-author.